MenPF-1 - A New Vaccine Against Meningococcal Disease
NCT01640652
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Serogroup B Meningococcal Disease
Interventions
BIOLOGICAL:
MenPF-1.
Sponsor
University of Oxford
Collaborators
[object Object]
[object Object]